Navigation Links
State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications

OSLO, Norway, June 15, 2012 /PRNewswire/ -- The Novelda NVA6000 series Impulse Radar transceivers are cutting-edge radar transceivers that incorporate extremely high frame rate and accuracy, in addition to unique penetration capabilities. Integrated on a single chip, this radar transceiver transmits pulses of high bandwidth.

In comparison to traditional technology, the Novelda NVA6000 Impulse Radar transceiver offers several improvements and value added features.

The ability to detect objects behind obstacles, coupled with increased speed and high sensitivity, not only makes it complementary and/or a substitute for existing technologies such as ultrasound, video and infrared sensors, but it has catered to new areas of applications as well.

The Novelda Impulse Radar transceiver successfully caters to sensor applications across a range of sectors including health monitoring (including stress and pulse monitoring), medical diagnosis (including heart beat monitoring and 3D RF-imaging), automotive and industrial (including distance and road obstacle detection), security surveillance (such as motion detection), and energy automation and defense.

"Unlike technologies that demand free visibility, Novelda NVA6000 Impulse Radar transceiver's ability to detect objects behind obstacles eliminates the need to clean lenses, thus ensuring cost savings for customers," concludes Novelda's CMO Aage Kalsaeg. "In addition, Novelda saves costs and time for developers by supplying development kits, radar modules and software, and providing development support for the entire range of available chips."

Please visit for application examples and ideas.


Novelda AS is a privately held, R&D driven semiconductor company based in Norway and specializing in nanoscale wireless low-power technology for ultra-high resolution impulse radar.

Novelda was founded in 2004 as a spin-out from the University of Oslo, and there is a strong Research & Development partnership with the university.

High-resolution images:

Novelda Development Kit with Sinuous antennas:

Novelda NVA6000 series Nanoscale Impulse Radar Chips:

Press Release Contact: Aage Kalsaeg; aage(at)

This press release was issued through eReleases® Press Release Distribution. For more information, visit

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
2. U Alberta finds weakness in armor of killer hospital bacteria
3. Study In Prenatal Diagnosis Finds Sequenom CMMs MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets
4. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
5. Study finds chronic abnormal brain blood flow in Gulf War veterans
6. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
7. Global Markets for Enzymes in Industrial Applications
8. TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications
9. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
10. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
11. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
Post Your Comments:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):